DAFNA Capital Management LLC
CIK 0001389933 · LOS ANGELES, CA · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$524.4M
2026 Q2
Positions
88
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
56.2%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
RVMD
REVOLUTION MEDICINES INC
20.1%
XBI
SPDR S&P BIOTECH ETF
5.9%
CMPS
COMPASS PATHWAYS PLC
5.4%
STXS
STEREOTAXIS INC
4.5%
NKTR
NEKTAR THERAPEUTICS
4.2%
DNLI
DENALI THERAPEUTICS INC
3.6%
IDYA
IDEAYA BIOSCIENCES INC
3.5%
ATRC
ATRICURE INC
3.2%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.